Surgery for drug-resistant tuberous sclerosis complex-associated epilepsy: who, when, and what
- PMID: 33720022
- DOI: 10.1684/epd.2021.1253
Surgery for drug-resistant tuberous sclerosis complex-associated epilepsy: who, when, and what
Abstract
Tuberous sclerosis complex (TSC) is a multisystem genetic disorder associated with refractory early-onset epilepsy. Current evidence supports surgery as the intervention most likely to achieve long-term seizure freedom, but no specific guidelines are available on TSC pre-surgical workup. This critical review assesses which TSC patients are suitable for surgical treatment, when pre-surgical evaluation should start, and what degree of surgical resection is optimal for postsurgical outcome. We searched for publications from 2000 to 2020 in Pubmed and Embase using the terms "tuberous sclerosis," "epilepsy," and "epilepsy surgery". To evaluate postsurgical seizure outcome, we selected only studies with at least one year of follow-up. Overall, we collected data on 1,026 patients from 34 studies. Age at surgery ranged from one month to 54 years. Mean age at surgery was 8.41 years. Of the diagnostic non-invasive pre-surgical tools, MRI and video-EEG were considered most appropriate. Promising data for epileptogenic tuber detection is provided from invasive SEEG studies. Data on surgery and related outcome were available for 769 patients. Seizure freedom was seen in 64.4% of patients who underwent tuberectomy, 68.9% treated with lobectomy and 65.1% with multilobar resection. The most effective surgical approach was lobectomy, even though more recently tuberectomy associated with the resection of the perituberal area seems to be the best approach to reach seizure freedom. Published postsurgical seizure freedom rates in patients with TSC were between 65% and 75%, but reduced to 48%-57% over longer follow-up periods. Early surgery might positively affect neurodevelopmental trajectory in some patients, even though data on cognitive outcome are still to be confirmed with longitudinal studies. Considering the strong correlation between epilepsy duration and neurocognitive outcome, all patients with TSC ought to be referred early to a dedicated epilepsy centre for individually tailored pre-surgical evaluation by a multi-disciplinary epilepsy surgery team.
Keywords: TSC; drug-resistant epilepsy; epilepsy surgery; infantile spasms; outcome.
Similar articles
-
Resective epilepsy surgery in tuberous sclerosis complex: a nationwide multicentre retrospective study from China.Brain. 2020 Feb 1;143(2):570-581. doi: 10.1093/brain/awz411. Brain. 2020. PMID: 31953931
-
Resective surgery in tuberous Sclerosis complex, from Penfield to 2018: A critical review.Rev Neurol (Paris). 2019 Mar;175(3):163-182. doi: 10.1016/j.neurol.2018.11.002. Epub 2019 Jan 25. Rev Neurol (Paris). 2019. PMID: 30686486 Review.
-
Resection of ictal high frequency oscillations is associated with favorable surgical outcome in pediatric drug resistant epilepsy secondary to tuberous sclerosis complex.Epilepsy Res. 2016 Oct;126:90-7. doi: 10.1016/j.eplepsyres.2016.07.005. Epub 2016 Jul 16. Epilepsy Res. 2016. PMID: 27450371
-
Resective Epilepsy Surgery for Tuberous Sclerosis in Children: Determining Predictors of Seizure Outcomes in a Multicenter Retrospective Cohort Study.Neurosurgery. 2015 Oct;77(4):517-24; discussion 524. doi: 10.1227/NEU.0000000000000875. Neurosurgery. 2015. PMID: 26120800
-
Epilepsy surgery and tuberous sclerosis complex: special considerations.Neurosurg Focus. 2008 Sep;25(3):E13. doi: 10.3171/FOC/2008/25/9/E13. Neurosurg Focus. 2008. PMID: 18759614 Review.
Cited by
-
Is tuberous sclerosis complex-associated autism a preventable and treatable disorder?World J Pediatr. 2024 Jan;20(1):40-53. doi: 10.1007/s12519-023-00762-2. Epub 2023 Oct 25. World J Pediatr. 2024. PMID: 37878130 Review.
-
Independent temporal lobe epilepsy in patients with tuberous sclerosis complex.Pediatr Investig. 2022 Mar 15;6(1):23-28. doi: 10.1002/ped4.12315. eCollection 2022 Mar. Pediatr Investig. 2022. PMID: 35382419 Free PMC article.
-
Prognostic application of lesion network mapping to epilepsy surgery outcomes in pediatric tuberous sclerosis complex.Epilepsia. 2025 Jun;66(6):1854-1864. doi: 10.1111/epi.18320. Epub 2025 Mar 5. Epilepsia. 2025. PMID: 40042434 Free PMC article.
-
The state of pediatric tuberous sclerosis complex epilepsy care: Results from a national survey.Epilepsia Open. 2022 Dec;7(4):718-728. doi: 10.1002/epi4.12652. Epub 2022 Oct 5. Epilepsia Open. 2022. PMID: 36161285 Free PMC article.
-
The effect of cannabidiol on seizure features and quality of life in drug-resistant frontal lobe epilepsy patients: a triple-blind controlled trial.Front Neurol. 2023 Jul 3;14:1143783. doi: 10.3389/fneur.2023.1143783. eCollection 2023. Front Neurol. 2023. PMID: 37470002 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical